Cargando…
Diabetic women: Inpatient mortality risk before SARS-CoV-2
BACKGROUND: Type 2 diabetes mellitus is a major driver of mortality worldwide. To assess the risk factors associated with diabetes that increase in-hospital mortality. METHODS: A retrospective cohort study was conducted using the National Hospital Morbidity with a sample of 3904 diabetic women admit...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023087/ https://www.ncbi.nlm.nih.gov/pubmed/35480137 http://dx.doi.org/10.1016/j.obmed.2022.100413 |
_version_ | 1784690257532289024 |
---|---|
author | Carrondo, Maria Cristina |
author_facet | Carrondo, Maria Cristina |
author_sort | Carrondo, Maria Cristina |
collection | PubMed |
description | BACKGROUND: Type 2 diabetes mellitus is a major driver of mortality worldwide. To assess the risk factors associated with diabetes that increase in-hospital mortality. METHODS: A retrospective cohort study was conducted using the National Hospital Morbidity with a sample of 3904 diabetic women admitted (2018–2019) in public hospitals, in Portugal. The type of comorbidities and the severity of the main disease – type 2 diabetes mellitus – was assessed based on the International Classification of Diseases (ICD-9) and Disease Staging. Cox proportional hazard was used to assess mortality during hospitalization. Mortality rates and mortality risk were the main outcome measures. RESULTS: In a total of 3904 diabetic women three hundred and eighty-nine (10.0%) died during hospitalization. Comorbidities bacterial pneumonia and coronary artery disease contributed 73% [Hazard ratio (HR) 1.73, 95% CI 1.32–2.27] and 37% [HR 1.37, 95% CI 1.03–1.81] respectively, to the risk of mortality, as did age over 65 years and severity 3 of the main disease. CONCLUSIONS: Women with advanced type 2 diabetes mellitus, advanced age, and with comorbidities such as pneumonia and coronary artery disease admitted urgently have a higher risk of mortality during hospitalization. |
format | Online Article Text |
id | pubmed-9023087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90230872022-04-22 Diabetic women: Inpatient mortality risk before SARS-CoV-2 Carrondo, Maria Cristina Obes Med Article BACKGROUND: Type 2 diabetes mellitus is a major driver of mortality worldwide. To assess the risk factors associated with diabetes that increase in-hospital mortality. METHODS: A retrospective cohort study was conducted using the National Hospital Morbidity with a sample of 3904 diabetic women admitted (2018–2019) in public hospitals, in Portugal. The type of comorbidities and the severity of the main disease – type 2 diabetes mellitus – was assessed based on the International Classification of Diseases (ICD-9) and Disease Staging. Cox proportional hazard was used to assess mortality during hospitalization. Mortality rates and mortality risk were the main outcome measures. RESULTS: In a total of 3904 diabetic women three hundred and eighty-nine (10.0%) died during hospitalization. Comorbidities bacterial pneumonia and coronary artery disease contributed 73% [Hazard ratio (HR) 1.73, 95% CI 1.32–2.27] and 37% [HR 1.37, 95% CI 1.03–1.81] respectively, to the risk of mortality, as did age over 65 years and severity 3 of the main disease. CONCLUSIONS: Women with advanced type 2 diabetes mellitus, advanced age, and with comorbidities such as pneumonia and coronary artery disease admitted urgently have a higher risk of mortality during hospitalization. The Author. Published by Elsevier Ltd. 2022-06 2022-04-22 /pmc/articles/PMC9023087/ /pubmed/35480137 http://dx.doi.org/10.1016/j.obmed.2022.100413 Text en © 2022 The Author Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Carrondo, Maria Cristina Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title | Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title_full | Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title_fullStr | Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title_full_unstemmed | Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title_short | Diabetic women: Inpatient mortality risk before SARS-CoV-2 |
title_sort | diabetic women: inpatient mortality risk before sars-cov-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023087/ https://www.ncbi.nlm.nih.gov/pubmed/35480137 http://dx.doi.org/10.1016/j.obmed.2022.100413 |
work_keys_str_mv | AT carrondomariacristina diabeticwomeninpatientmortalityriskbeforesarscov2 |